STAT Plus: Pfizer says efficacy of its Duchenne gene therapy outweighs side effects
Pfizer’s experimental gene therapy to treat Duchenne muscular dystrophy appeared to improve muscle function in a study of nine boys, but also resulted in serious drug reactions in three of those children, the company said Friday.
The data are being presented at a virtual session of the American Society of Gene & Cell Therapy.
Continue to STAT Plus to read the full story…
